THROMBIN TOPICAL RECOMBINANT

THROMBIN TOPICAL RECOMBINANT was reported 68 times

THROMBIN TOPICAL RECOMBINANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PNEUMORETROPERITONEUM 1 0.0133
1 AMMONIA DECREASED 1 0.0128
2 OUT OF SPECIFICATION TEST RESULTS 1 0.0100
3 CEREBRAL VASCULAR OCCLUSION 1 0.0087
4 BURKHOLDERIA TEST POSITIVE 1 0.0081
5 PH BODY FLUID ABNORMAL 1 0.0072
6 ASPERGILLUS TEST POSITIVE 2 0.0065
7 FACTOR V DEFICIENCY 1 0.0063
8 POST PROCEDURAL STROKE 1 0.0054
9 LOWER RESPIRATORY TRACT INFECTION FUNGAL 2 0.0051
10 RIGHT-TO-LEFT CARDIAC SHUNT 1 0.0045
11 VENOUS OCCLUSION 8 0.0044
12 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
13 VENOUS HAEMORRHAGE 1 0.0032
14 PRODUCT RECONSTITUTION ISSUE 1 0.0032
15 CRANIAL NERVE DISORDER 2 0.0029
16 CAPILLARY DISORDER 1 0.0026
17 RETICULOCYTE COUNT DECREASED 1 0.0023
18 ARTERIAL STENOSIS 2 0.0023
19 HYPERLEUKOCYTOSIS 2 0.0023
20 PNEUMATOSIS 1 0.0022
21 OPERATIVE HAEMORRHAGE 1 0.0022
22 KIDNEY ENLARGEMENT 2 0.0018
23 PRODUCT NAME CONFUSION 2 0.0018
24 CEREBRAL VENTRICLE DILATATION 2 0.0017
25 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
26 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
27 SLOW RESPONSE TO STIMULI 2 0.0015
28 CYTOKINE STORM 1 0.0015
29 PRODUCT DESIGN ISSUE 1 0.0014
30 COAGULATION TEST ABNORMAL 1 0.0013
31 BLOOD FIBRINOGEN INCREASED 1 0.0013
32 PHARYNGEAL PARAESTHESIA 2 0.0013
33 VASCULAR PSEUDOANEURYSM 2 0.0011
34 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
35 MITRAL VALVE DISEASE 2 0.0011
36 BLOOD MAGNESIUM INCREASED 1 0.0011
37 BLAST CELL COUNT INCREASED 1 0.0010
38 HYDROCELE 1 0.0009
39 HYPERPHOSPHATAEMIA 2 0.0009
40 WRONG PRODUCT ADMINISTERED 6 0.0009
41 DRUG EFFECT VARIABLE 1 0.0009
42 BLOOD FIBRINOGEN DECREASED 1 0.0009
43 CARBON DIOXIDE DECREASED 1 0.0009
44 PROCALCITONIN INCREASED 1 0.0009
45 CEREBRAL ARTERY EMBOLISM 1 0.0008
46 BLOOD UREA DECREASED 1 0.0008
47 HEPATOSPLENOMEGALY 2 0.0008
48 IATROGENIC INJURY 1 0.0008
49 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
50 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
51 ANION GAP INCREASED 1 0.0007
52 LUNG CONSOLIDATION 2 0.0007
53 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
54 INTRACARDIAC THROMBUS 2 0.0007
55 TRANSCRIPTION MEDICATION ERROR 1 0.0006
56 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
57 CUSHINGOID 2 0.0006
58 THROMBOSIS IN DEVICE 2 0.0006
59 TONSILLECTOMY 1 0.0006
60 BLOOD CHLORIDE INCREASED 1 0.0006
61 PNEUMONIA FUNGAL 2 0.0005
62 CEREBRAL ATROPHY 2 0.0005
63 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
64 PRODUCT PACKAGING CONFUSION 1 0.0004
65 RETINAL ARTERY OCCLUSION 1 0.0004
66 ABDOMINAL INFECTION 1 0.0004
67 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
68 ENDOTRACHEAL INTUBATION 1 0.0004
69 PNEUMATOSIS INTESTINALIS 1 0.0004
70 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
71 PRODUCT LABEL CONFUSION 2 0.0003
72 WRONG DRUG ADMINISTERED 3 0.0003
73 BRAIN HERNIATION 1 0.0003
74 BRAIN DEATH 1 0.0003
75 BLOOD CREATININE DECREASED 1 0.0003
76 RESPIRATORY RATE DECREASED 1 0.0003
77 PRODUCT PACKAGING ISSUE 3 0.0003
78 MONOCYTE COUNT INCREASED 1 0.0003
79 BLOOD PHOSPHORUS DECREASED 1 0.0003
80 PROTEIN TOTAL DECREASED 1 0.0003
81 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
82 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
83 FACIAL PARALYSIS 2 0.0002
84 SKIN HYPERPIGMENTATION 2 0.0002
85 TUMOUR LYSIS SYNDROME 2 0.0002
86 ANAL INCONTINENCE 2 0.0002
87 LOCALISED OEDEMA 1 0.0002
88 PULSE ABSENT 1 0.0002
89 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
90 CEREBRAL ISCHAEMIA 1 0.0002
91 SERUM FERRITIN INCREASED 1 0.0002
92 BACTERAEMIA 2 0.0002
93 PROTHROMBIN TIME PROLONGED 1 0.0002
94 INJECTION SITE EXTRAVASATION 2 0.0002
95 BRAIN OEDEMA 2 0.0002
96 PRODUCT LABEL ISSUE 1 0.0001
97 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
98 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
99 GRAFT VERSUS HOST DISEASE 1 0.0001
100 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
101 DRUG ADMINISTRATION ERROR 4 0.0001
102 BLOOD ALBUMIN DECREASED 1 0.0001
103 EMBOLISM 1 0.0001
104 PRODUCT CONTAINER ISSUE 1 0.0001
105 UNRESPONSIVE TO STIMULI 3 0.0001
106 SPINAL OSTEOARTHRITIS 1 0.0001
107 MEDICATION ERROR 6 0.0001
108 POST PROCEDURAL COMPLICATION 2 0.0001
109 BRAIN INJURY 1 0.0001
110 PRODUCT DISPENSING ERROR 2 0.0001
111 VENTRICULAR FIBRILLATION 1 0.0001
112 BLOOD CALCIUM DECREASED 1 0.0001
113 CHROMATURIA 2 0.0001
114 ENCEPHALOPATHY 2 0.0001
115 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
116 TACHYPNOEA 1 0.0001
117 CARDIO-RESPIRATORY ARREST 3 0.0001
118 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
119 PARAESTHESIA ORAL 1 0.0001
120 URINARY INCONTINENCE 2 0.0001
121 DRUG DISPENSING ERROR 1 0.0001
122 EJECTION FRACTION DECREASED 1 0.0001
123 ACUTE MYELOID LEUKAEMIA 1 0.0001
124 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
125 COAGULOPATHY 1 0.0001
126 HAEMATURIA 2 0.0001
127 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
128 LYMPHOCYTE COUNT DECREASED 1 0.0001
129 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
130 LYMPHADENOPATHY 2 0.0001
131 ISCHAEMIC STROKE 1 0.0001
132 LEUKOCYTOSIS 1 0.0001
133 C-REACTIVE PROTEIN INCREASED 2 0.0001
134 HYPERGLYCAEMIA 2 0.0001
135 EPISTAXIS 4 0.0001
136 BLOOD SODIUM DECREASED 1 0.0001
137 ACUTE RESPIRATORY FAILURE 1 0.0001
138 SINUS DISORDER 1 0.0001
139 HAEMATOCRIT DECREASED 1 0.0001
140 CYTOKINE RELEASE SYNDROME 1 0.0000
141 THROMBOSIS 4 0.0000
142 PLEURAL EFFUSION 3 0.0000
143 INJURY ASSOCIATED WITH DEVICE 1 0.0000
144 MENTAL DISORDER 2 0.0000
145 THERAPY NON-RESPONDER 2 0.0000
146 HYPOKALAEMIA 2 0.0000
147 PRESYNCOPE 1 0.0000
148 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
149 HAEMATEMESIS 1 0.0000
150 MUCOSAL INFLAMMATION 1 0.0000
151 PALLOR 1 0.0000
152 PANCYTOPENIA 2 0.0000
153 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
154 RED BLOOD CELL COUNT DECREASED 1 0.0000
155 ACUTE MYOCARDIAL INFARCTION 1 0.0000
156 BLOOD POTASSIUM DECREASED 1 0.0000
157 PULMONARY EMBOLISM 3 0.0000
158 FEBRILE NEUTROPENIA 2 0.0000
159 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
160 NEOPLASM PROGRESSION 1 0.0000
161 HYPOXIA 1 0.0000
162 SEIZURE 3 0.0000
163 NEUTROPHIL COUNT DECREASED 1 0.0000
164 ANGIOEDEMA 1 0.0000
165 BLOOD CHOLESTEROL INCREASED 1 0.0000
166 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
167 NEUROPATHY PERIPHERAL 2 0.0000
168 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
169 ABDOMINAL DISTENSION 2 0.0000
170 PARAESTHESIA 3 0.0000
171 PANCREATITIS 1 0.0000
172 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
173 OEDEMA 1 0.0000
174 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
175 TREMOR 3 0.0000
176 CONVULSION 1 0.0000
177 LETHARGY 1 0.0000
178 NO ADVERSE EVENT 3 0.0000
179 FEELING HOT 1 0.0000
180 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
181 DEEP VEIN THROMBOSIS 1 0.0000
182 DEVICE DIFFICULT TO USE 1 0.0000
183 BLOOD PRESSURE DECREASED 1 0.0000
184 HYPOTENSION 3 0.0000
185 PRODUCT QUALITY ISSUE 2 0.0000
186 HYPERTENSION 3 0.0000
187 DECREASED APPETITE 3 0.0000
188 CARDIAC FAILURE CONGESTIVE 1 0.0000
189 CONFUSIONAL STATE 2 0.0000
190 CARDIAC ARREST 1 0.0000
191 CEREBROVASCULAR ACCIDENT 2 0.0000
192 PYREXIA 4 0.0000
193 TACHYCARDIA 1 0.0000
194 DEVICE ISSUE 1 0.0000
195 COUGH 3 0.0000
196 CARDIAC DISORDER 1 0.0000
197 BLOOD GLUCOSE INCREASED 2 0.0000
198 SYNCOPE 1 0.0000
199 FLUSHING 1 0.0000
200 HAEMORRHAGE 1 0.0000
201 PLATELET COUNT DECREASED 1 0.0000
202 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
203 THROMBOCYTOPENIA 1 0.0000
204 DISEASE PROGRESSION 1 0.0000
205 RENAL FAILURE 1 0.0000
206 HYPOAESTHESIA 1 0.0000
207 VOMITING 3 0.0000
208 URINARY TRACT INFECTION 1 0.0000
209 COVID-19 1 0.0000
210 ANAEMIA 1 0.0000
211 HEADACHE 3 0.0000
212 DRUG INEFFECTIVE 6 0.0000
213 DYSPNOEA 2 0.0000
214 CONDITION AGGRAVATED 1 0.0000
215 INJECTION SITE PAIN 1 0.0000
216 PNEUMONIA 1 0.0000
217 RASH 1 0.0000
218 OFF LABEL USE 2 0.0000
219 MALAISE 1 0.0000
220 PAIN 1 0.0000
221 NAUSEA 1 0.0000
222 DEATH 1 0.0000